Cargando…
Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure
Rabies is a deadly viral zoonosis with global disease burden. Following exposure to a rabid animal, post-exposure prophylaxis (PEP) is the standard of care for unvaccinated persons. Despite the large proportion of pediatric cases, limited safety and efficacy data exist for use in pediatric patients....
Autores principales: | Hobart-Porter, Nicholas, Stein, Michal, Toh, Naveh, Amega, Novinyo, Nguyen, Huy-Binh, Linakis, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189119/ https://www.ncbi.nlm.nih.gov/pubmed/33563087 http://dx.doi.org/10.1080/21645515.2020.1854000 |
Ejemplares similares
-
Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
por: Burke, Rita V, et al.
Publicado: (2022) -
Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures
por: Haradanhalli, Ravish S., et al.
Publicado: (2022) -
An epidemiological study of suspected rabies exposures and adherence to rabies post-exposure prophylaxis in Eastern Thailand, 2015
por: Yurachai, Onphirul, et al.
Publicado: (2020) -
Rabies immunoglobulin should not be forgotten in category III exposure
por: Gozdas, Hasan Tahsin
Publicado: (2021) -
Rabies postexposure prophylaxis in the United States: Opportunities to improve access, coordination, and delivery
por: Howington, Gavin T., et al.
Publicado: (2021)